Target intelligence / Profile preview

NAD-dependent protein deacetylase sirtuin 3, mitochondrial (SIRT3)

Target
SIRT3
Molecular classification
Enzyme, Sirtuin family, Class I sirtuin, Lysine deacetylase, Mono-ADP-ribosyltransferase
01

Overview

NAD-dependent protein deacetylase sirtuin 3, mitochondrial (SIRT3) is the primary protein deacetylase located within the mitochondrial matrix, where it serves as a master regulator of metabolic homeostasis [UniProt: Q9NTG7]. It utilizes NAD+ as a co-substrate to remove acetyl groups from various metabolic enzymes, thereby coordinating the tricarboxylic acid (TCA) cycle, fatty acid oxidation, and the urea cycle in response to cellular energy demands [PMID: 21167305]. A critical function of SIRT3 is the regulation of mitochondrial oxidative stress; by deacetylating and activating superoxide dismutase 2 (SOD2), it facilitates the scavenging of reactive oxygen species and protects the cell from oxidative damage [PMID: 21126506]. In human pathology, reduced SIRT3 activity is linked to the development of metabolic syndrome, cardiac hypertrophy, and neurodegenerative conditions like Alzheimer's disease [PMID: 23603399]. Conversely, its role in cancer is dualistic, acting as a tumor suppressor by maintaining genomic stability or as a survival factor for certain established tumors. Therapeutic interest focuses on SIRT3 activators, such as honokiol, to treat age-related metabolic and cardiovascular diseases, while selective inhibitors like 3-TYP are primarily used as research tools to investigate its complex biological roles [PMID: 25605930, PMID: 24513116].

Other names
Sirtuin 3SIR2L3SIR2-like protein 3Mitochondrial sirtuinRegulatory protein SIR2 homolog 3
02

Mechanism of action

SIRT3 functions as an NAD+-dependent deacetylase that removes acetyl groups from lysine residues of mitochondrial proteins, thereby modulating their enzymatic activity and metabolic flux [PMID: 21167305]. It also exhibits mono-ADP-ribosyltransferase activity. By activating antioxidant enzymes such as superoxide dismutase 2 (SOD2) through deacetylation at K122, SIRT3 reduces mitochondrial reactive oxygen species (ROS) levels [PMID: 21126506].

03

Biological functions

Mitochondrial homeostasisEnergy metabolism regulationOxidative stress responseApoptosis regulationFatty acid oxidationTricarboxylic acid cycle regulationThermogenesisUrea cycle regulation
04

Disease associations

Cardiovascular diseaseMetabolic syndromeType 2 diabetesNeurodegenerative diseaseCancerAge-related hearing lossNon-alcoholic fatty liver disease
05

Safety considerations

Off-target effects on other sirtuin isoforms (SIRT1, SIRT2, SIRT4, SIRT5)Context-dependent role in oncology where SIRT3 can act as either a tumor suppressor or a promoterPotential for metabolic dysregulation if over-activated or inhibited non-specificallyChallenges in achieving mitochondrial-specific delivery of small molecules
06

Interacting drugs

Honokiol

7 more in the full profile.

07

Biomarkers

Acetylated Superoxide Dismutase 2 (K122)SIRT3 mRNA/protein expression levelsNAD+/NADH ratioAcetylated Long-chain acyl-CoA dehydrogenase (LCAD)Mitochondrial protein acetylation profile

Beyond the preview

Go deeper on NAD-dependent protein deacetylase sirtuin 3, mitochondrial (SIRT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAD-dependent protein deacetylase sirtuin 3, mitochondrial (SIRT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call